Closure Medical (Nasdaq: CLSR) said Monday that it had received approval from the US Federal Trade Commission for its acquisition by Johnson & Johnson.

J&J announced its intention to acquire Closure on March 4 for $370 million, or $27 a share. Closure stock closed at $26.94 on Monday.

Closure said the deal should close shortly after its meeting with stockholders on June 2 when their approval of the transaction will be sought.